taihua plc (TAIH) Snapshot

taihua plc (TAIH) Details

Taihua plc, an investment holding company, engages in the manufacture and sale of pharmaceutical products in the People’s Republic of China. The company operates through four segments: Paclitaxel, Homoharringtonine, Traditional Chinese Medicines (TCM) Products, and Forsythia. It develops, manufactures, and distributes active pharmaceutical ingredients, which comprise paclitaxel that is extracted from yew tree for use in the treatement of ovaries, breast, lungs, skin, and mucous membranes cancer; and Homoharringtonine, an alkaloid extracted from cephalotaxus tree for use in the treatement of acute myeloid leukaemia and other cancers. The company also develops, produces, distributes, and sells TCM products, including Gengnianan tablets for use in the treatment of symptoms of menopause; Duzhong Pingya tablets for use in the treatment of high blood pressure; Zaoren Anshen Keli for use in the treatment of insomnia and headaches caused by neurological problems; and Bunao Anshen tablets for use in the treatment of headaches, insomnia, and palpitation. Its TCM products also consist of Jiangzi Jianfei tablets for cholesterol and help weight loss; Dabaidu capsules for the treatment of urinary infection; Runing tablets for use in the treatment of pain of sore breasts; and Bian Tong Pian for use in the treatment of constipation. In addition, Taihua plc is involved in the cultivation, harvest, and sale of Forsythia, a flowering shrub for use as raw material in TCM preparations. The company was formerly known as China Natural Plc and changed its name to Taihua plc in September 2006. Taihua plc was incorporated in 2006 and is based in Xian, the People’s Republic of China.

taihua plc (TAIH) Top Compensated Officers